Skip to main content

Atrium Hernia Mesh Lawsuit Filed

Atrium Hernia Mesh Lawsuit Filed

Atrium Hernia Mesh Lawsuit Filed

Introduction

Lawsuits involving Nexium, Prilosec, Prevacid, and other proton pump inhibitors have grown up to nearly 14,000 cases filed across the federal court system.

According to a joint status report submitted on April 17, by the parties involved in the litigation to the U.S. District Judge Claire C. Cecchi, there are at least  13,919 lawsuits filed, involving 13,950 different plaintiffs.

There are also more than 200 similar lawsuits filed in various state courts, including Delaware, Illinois, New Jersey, and Ohio.

The report also stated various agenda items for the status conference held on April 22. During the conference, the parties updated Judge Cecchi on the status of bellwether trial pool selections, the discovery proceedings, and other actions to move the litigation forward.

The lawsuits are consolidated under MDL No. 2789 presided by U.S. District Judge Claire C. Cecchi. Each plaintiff claims that the manufacturers failed to warn about the risk of chronic kidney disease associated with the widely used heartburn and acid reflux drugs.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

First Federal Bellwether Trial Set in Strattice Mesh Case

Categories: Hernia Mesh

Lawyers involved in federal Strattice hernia mesh litigation are scheduled to meet with the presiding judge in the U.S. District Court for the District of New Jersey to…

Tepezza Hearing Loss Trial Set for June 2026

Categories: Tepezza

The U.S. District Judge overseeing all federal Tepezza lawsuits has postponed the start of the first bellwether trial by 60 days.

This decision comes as attorneys…

FDA Moves to Restrict Dangerous 7-OH Opioid Products

Categories: Opioids

In a significant move to combat the ongoing opioid crisis, the U.S. Food and Drug Administration (FDA) has recommended a scheduling action under the Controlled Substances Act (CSA) to regulate certain products containing 7-hydroxymitragynine (7-…

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!